Free Trial
→ Why I'm telling friends to avoid gold stocks (From DTI) (Ad) Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) Insider Trading & Ownership

4D Molecular Therapeutics logo
$5.88 -0.43 (-6.81%)
(As of 05:45 PM ET)
Compare

4D Molecular Therapeutics (NASDAQ:FDMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$16.38 M
Get FDMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FDMT Insider Buying and Selling by Quarter

Ad DTI
Forced out of retirement by these trades
You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed
Make sure to check out Gamma Pockets HERE while it’s still widely available 

4D Molecular Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2024Scott BizilyInsiderSell500$16.33$8,165.00  
7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.50  
7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.00  
7/10/2024David KirnCEOSell12,923$22.49$290,638.27  
7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.28  
6/24/2024David KirnCEOSell12,930$23.10$298,683.00  
5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.50  
4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.00  
4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.34  
3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.32  
3/18/2024Scott BizilyInsiderSell1,750$31.27$54,722.50  
2/27/2024Scott BizilyInsiderSell1,909$30.00$57,270.00  
2/16/2024Scott BizilyInsiderSell1,750$27.67$48,422.50  
2/8/2024David KirnCEOSell92,001$27.13$2,495,987.13  
2/8/2024Scott BizilyInsiderSell6,244$27.50$171,710.00  
2/5/2024Robert Young KimInsiderSell24,552$30.05$737,787.60  
1/23/2024David KirnCEOSell5,696$18.41$104,863.36  
1/4/2024David KirnCEOSell40,732$20.31$827,266.92  
1/4/2024Global Investors Lp VikingMajor ShareholderSell540,000$19.53$10,546,200.00  
(Data available from 1/1/2013 forward)

FDMT Insider Trading Activity - Frequently Asked Questions

The list of insiders at 4D Molecular Therapeutics includes David Kirn, Global Investors Lp Viking, Jacob Chacko, Robert Young Kim, and Scott Bizily. Learn more on insiders at FDMT.

7.30% of 4D Molecular Therapeutics stock is owned by insiders. Learn more on FDMT's insider holdings.

The following insider purchased FDMT shares in the last 24 months: Global Investors Lp Viking ($13,600,000.00).

Insiders have purchased a total of 850,000 FDMT shares in the last 24 months for a total of $13,600,000.00 bought.

The following insiders have sold FDMT shares in the last 24 months: David Kirn ($4,612,962.77), Global Investors Lp Viking ($10,546,200.00), Jacob Chacko ($100,250.00), Robert Young Kim ($737,787.60), and Scott Bizily ($1,319,159.41).

Insiders have sold a total of 812,358 4D Molecular Therapeutics shares in the last 24 months for a total of $17,316,359.78 sold.

4D Molecular Therapeutics Key Executives

  • Dr. John F. Milligan Ph.D. (Age 63)
    Executive Chairman
    Compensation: $150k
  • Dr. David H. Kirn M.D. (Age 61)
    Co-Founder, CEO & Director
    Compensation: $1.01M
  • Dr. Fariborz Kamal Ph.D. (Age 61)
    President & COO
    Compensation: $786.2k
  • Dr. Noriyuki Kasahara M.D. (Age 61)
    Ph.D., Chief Scientific Officer
    Compensation: $201.29k
  • Dr. Robert Y. Kim M.B.A. (Age 63)
    M.D., Chief Medical Officer
    Compensation: $704.84k
  • Ms. Theresa Janke (Age 49)
    Co-Founder & Chief of Staff
    Compensation: $652.32k
  • Mr. Uneek Mehra (Age 52)
    Chief Financial & Business Officer
  • Dr. Scott P. Bizily J.D. (Age 51)
    Ph.D., Chief Legal Officer & Corporate Secretary
  • Dr. An Song Ph.D.
    Chief Development Officer
  • Dr. Alan H. Cohen FAAAAI (Age 63)
    FAAP, FACAAI, FCCP, M.D., Senior VP & Therapeutic Area Head of Pulmonology

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:FDMT) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Behind the Markets | Sponsored
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored